These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32384089)

  • 41. Animal models of malignant pleural effusion.
    Stathopoulos GT; Kalomenidis I
    Curr Opin Pulm Med; 2009 Jul; 15(4):343-52. PubMed ID: 19387350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
    Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
    Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myelomatous pleural effusion: a case series in a single institution and literature review.
    Cho YU; Chi HS; Park CJ; Jang S; Seo EJ; Suh C
    Korean J Lab Med; 2011 Oct; 31(4):225-30. PubMed ID: 22016674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
    Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
    Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients: A multicenter retrospective study.
    Roh J; Ahn HY; Kim I; Son JH; Seol HY; Kim MH; Lee MK; Eom JS
    Medicine (Baltimore); 2021 May; 100(19):e25748. PubMed ID: 34106603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real-world study.
    Wang B; Zhong C; Liao Z; Wang H; Cai X; Zhang Y; Wang J; Wang T; Yao H
    Thorac Cancer; 2023 Oct; 14(30):3051-3057. PubMed ID: 37675621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitivity of Initial Thoracentesis for Malignant Pleural Effusion Stratified by Tumor Type in Patients with Strong Evidence of Metastatic Disease.
    Grosu HB; Kazzaz F; Vakil E; Molina S; Ost D
    Respiration; 2018; 96(4):363-369. PubMed ID: 30016797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
    Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
    J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
    Tang Y; Wang Z; Li Z; Kim J; Deng Y; Li Y; Heath JR; Wei W; Lu S; Shi Q
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2544-2549. PubMed ID: 28223509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
    Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
    Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
    Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
    BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small-Cell Lung Carcinoma. The Effect of Preanalytical Factors.
    Carter J; Miller JA; Feller-Kopman D; Ettinger D; Sidransky D; Maleki Z
    Ann Am Thorac Soc; 2017 Jul; 14(7):1169-1176. PubMed ID: 28557526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malignant pleural effusion cell blocks are substitutes for tissue in EML4-ALK rearrangement detection in patients with advanced non-small-cell lung cancer.
    Zhong J; Li X; Bai H; Zhao J; Wang Z; Duan J; An T; Wu M; Wang Y; Wang S; Wang J
    Cytopathology; 2016 Dec; 27(6):433-443. PubMed ID: 27060609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosing malignant pleural effusion using clinical and analytical parameters.
    Pan Y; Bai W; Chen J; Mao Y; Qian X; Xu K; Tang S; Zhang J; Chen C; Chen J; Hu X
    J Clin Lab Anal; 2019 Feb; 33(2):e22689. PubMed ID: 30390322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sarcopenia in patients with malignant pleural effusion: impact on symptoms, health status, and response to hospitalization.
    Rodríguez-Torres J; López-López L; Cabrera-Martos I; Valenza-Demet G; Cahalin LP; Valenza MC
    Support Care Cancer; 2019 Dec; 27(12):4655-4663. PubMed ID: 30944992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
    Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.
    Hung TL; Chen FF; Liu JM; Lai WW; Hsiao AL; Huang WT; Chen HH; Su WC
    Clin Cancer Res; 2003 Jul; 9(7):2605-12. PubMed ID: 12855637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.
    Thompson JC; Fan R; Black T; Yu GH; Savitch SL; Chien A; Yee SS; Sen M; Hwang WT; Katz SI; Feldman M; Vachani A; Carpenter EL
    Lung Cancer; 2019 Jan; 127():25-33. PubMed ID: 30642547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.
    Shin YM; Yun J; Lee OJ; Han HS; Lim SN; An JY; Lee KH; Lee KM; Choe KH
    Cancer Res Treat; 2014 Apr; 46(2):178-85. PubMed ID: 24851110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.